Results 111 to 120 of about 7,548 (263)

Travelling Across Time Zones With Type 1 Diabetes: A Pilot Study Comparing Insulin Degludec With Insulin Glargine U100

open access: gold, 2021
Wendy C. Bevier   +9 more
openalex   +1 more source

Role of Continuous Glucose Monitoring in Clinical Trials: Recommendations on Reporting. [PDF]

open access: yes, 2017
Thanks to significant improvements in the precision, accuracy, and usability of continuous glucose monitoring (CGM), its relevance in both ambulatory diabetes care and clinical research is increasing.
Barnard, Katharine   +15 more
core   +2 more sources

Efficacy and safety of basal insulins in people with type 2 diabetes mellitus: a systematic review and network meta-analysis of randomized clinical trials

open access: yesFrontiers in Endocrinology
AimThe comparative effectiveness of basal insulins has been examined in several studies. However, current treatment algorithms provide a list of options with no clear differentiation between different basal insulins as the optimal choice for initiation ...
Mohsen Dehghani   +12 more
doaj   +1 more source

Cost-Effectiveness of Insulin Degludec Versus Insulin Glargine U100 in Patients with Type 1 and Type 2 Diabetes Mellitus in Serbia [PDF]

open access: gold, 2018
Nebojša Lalić   +4 more
openalex   +1 more source

A E uropean, multicentre, retrospective, non‐interventional study ( EU‐TREAT ) of the effectiveness of insulin degludec after switching basal insulin in a population with type 1 or type 2 diabetes [PDF]

open access: hybrid, 2017
Thorsten Siegmund   +8 more
openalex   +1 more source

Adjunct Therapy in Type 1 Diabetes: A Survey to Uncover Unmet Needs and Patient Preferences Beyond HbA1c Measures. [PDF]

open access: yes, 2019
Background: Adjunct therapy can help patients with type 1 diabetes achieve glycemic goals while potentially mitigating some of the side effects of insulin.
Berria, Rachele   +8 more
core  

Optimal Regulation of Blood Glucose Level in Type I Diabetes using Insulin and Glucagon

open access: yes, 2019
The Glucose-Insulin-Glucagon nonlinear model [1-4] accurately describes how the body responds to exogenously supplied insulin and glucagon in patients affected by Type I diabetes.
Della Rossa, Fabio   +4 more
core   +4 more sources

Author response for "A Randomised Controlled Trial Comparing Insulin Degludec U100 and Glargine U100 for the Inpatient Management of Patients with Type 2 Diabetes"

open access: gold, 2021
Rodolfo J. Galindo   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy